Capital Flow Monitor · Sponsors · CIK 2139514
Memento Medicines, Inc.
200 BERKELEY ST., BOSTON, MA, 02116 · 518-313-0994
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$93.0M
Sold
$38.0M
% sold
40.9%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | D ·current | 506(b) | $93.0M | $38.0M | 40.9% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Naveen Manu Daryani — Executive Officer / Director / Promoter, Boston, MA
1 other raise
- Lonestar Medicines, Inc. $25.0M of $45.0M · 55.6%
-
William Daley Bonificio — Executive Officer / Promoter, Boston, MA
1 other raise
- Lonestar Medicines, Inc. $25.0M of $45.0M · 55.6%
-
Stephen Basil Thomas — Executive Officer / Promoter, Boston, MA
1 other raise
- Lonestar Medicines, Inc. $25.0M of $45.0M · 55.6%
-
Zach Scheiner — Director, Boston, MA
1 other raise
- Sparrow Pharmaceuticals, Inc. $61.8M of $121.4M · 50.9%
- Dmitrij Hristodorov — Director, Boston, MA
- Megan Krench — Director, Boston, MA
- Vishal Kapoor — Director, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.